Device / Technology News

RSS

Medtronic announces international launch of Resolute Integrity Stent System

Medtronic, Inc. (NYSE: MDT), announces the CE (Conformite Europeene) mark and international launch of the Resolute Integrity Stent System for the treatment of coronary artery disease, a leading cause of death and poor quality of life.

7 Sep 2010

DSM, PolyTherics enter agreement for HiPEG IFN alpha-2a product development

DSM BioSolutions, DSM's microbial fermentation CMO business unit and PolyTherics Limited an innovator in precision engineering of proteins, today announced that they have entered into an agreement for the process development and manufacture of PolyTherics' lead biobetter product, HiPEG IFN alpha-2a.

7 Sep 2010

International Iberian Nanotechnology Laboratory orders for Vistec's EBPG5200 electron-beam lithography system

Vistec Lithography, a leading supplier of advanced electron-beam lithography systems has announced today that the International Iberian Nanotechnology Laboratory (INL) in Braga, Portugal has placed an order for Vistec's electron-beam lithography system EBPG5200. The Portuguese Laboratory is the first fully international research organization in Europe in the field of nanoscience and nanotechnology.

7 Sep 2010

Ultrasound guidance helps radiologist to identify, treat self-embedding patients

Using ultrasound and a minimally-invasive procedure, radiologists can identify and treat patients who engage in a disturbing self-injury behavior known as self-embedding, according to a new study published in the online edition and October print issue of the journal Radiology.

7 Sep 2010

Researchers decode words from brain signals in paralyzed people

In an early step toward letting severely paralyzed people speak with their thoughts, University of Utah researchers translated brain signals into words using two grids of 16 microelectrodes implanted beneath the skull but atop the brain. "We have been able to decode spoken words using only signals from the brain with a device that has promise for long-term use in paralyzed patients who cannot now speak," says Bradley Greger, an assistant professor of bioengineering.

7 Sep 2010

Myconostica's MycAssay Aspergillus for serum granted CE marking

Myconostica Ltd, the UK-based medical diagnostic company developing and commercialising rapid and highly specific tests for life-threatening fungal infections, today announces the CE marking of its lead product MycAssay™ Aspergillus for detection of Aspergillus DNA in serum.

6 Sep 2010

PennHIP radiographic method may hold potential to evaluate human susceptibility to hip dysplasia

A study comparing a University of Pennsylvania method for evaluating a dog's susceptibility to hip dysplasia to the traditional American method has shown that 80 percent of dogs judged to be normal by the traditional method are actually at risk for developing osteoarthritis and hip dysplasia, according to the Penn method.

4 Sep 2010

Exmovere commences development of urban electric vehicle for active women

Exmovere Holdings, Inc., a biomedical engineering company, today announced that it is developing a stand and ride road vehicle to complement its Chariot product line, called the "Red Fury." On June 22nd of this year, Exmovere Holdings engaged Sarah Park as lead industrial designer for this product. The Red Fury is an urban electric vehicle that is based on Sarah Park's unique trapezoid-based design language and is intended to supplant mopeds and electric bicycles.

4 Sep 2010

Study suggest PET/CT scanning may offer effective breast cancer detection, spread

About one-third of women diagnosed with early-stage breast cancer will have their cancer travel, or metastasize, to other parts of the body, with the bone being the most common site of initial detectable spread. Controversy continues to surround the question of whether CT and bone scans should be standard in evaluating patients for these metastases, or whether integrated PET/CT scanning might be more effective at detecting breast tumors that have reached nearby bones.

4 Sep 2010

MSKCC develops new prediction tool to calculate risk for DCIS recurrence after breast-conserving surgery

The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.

4 Sep 2010

FDA approves IDE study to evaluate HeartWare Ventricular Assist System

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption) Supplement that allows HeartWare to enroll a second allotment of 54 patients in its "ADVANCE" bridge-to-transplant clinical trial under a Continued Access Protocol (CAP).

4 Sep 2010

Revolutions Medical signs Letter of Intent for manufacturing RevVac Safety Syringes

Revolutions Medical signs Letter of Intent today with Medical Investment Group, LLC (MIG) for the Manufacturing of the RevVac Safety Syringe. The final terms are expected to be completed in definitive documents between the parties no later than September 17th, 2010.

4 Sep 2010

TNS therapy improves depression: Study

Major depression is a common and disabling brain condition marked not only by the presence of depressed mood but also by its effects on sleep, energy, decision-making, memory and thoughts of death or of suicide.

3 Sep 2010

Virginia G. Piper Cancer Center at Scottsdale Healthcare offers free prostate cancer screenings

Recognizing that early detection can save lives, the Virginia G. Piper Cancer Center at Scottsdale Healthcare is offering free prostate cancer screenings from 8:30 a.m.-12 p.m. on Saturday, Sept. 11.

3 Sep 2010

Transitions Optical launches 'Healthy Sight for Life: Focus on African-American Eyes' campaign

Recognizing the increased risks African Americans face for a number of eye health issues, Transitions Optical, Inc., the leading supplier of photochromic eyeglass lenses, is launching its "Healthy Sight for Life: Focus on African-American Eyes" campaign at the National Council of Negro Women (NCNW)'s 25th annual Black Family Reunion Celebration on September 11 in Washington, D.C.

3 Sep 2010

ForteBio launches Protein G biosensor for rapid detection of mammalian IgGs

ForteBio®, Inc., a leading supplier of label-free technology that accelerates the development of biotherapeutic and pharmaceutical products, today announced the launch of its Dip and Read™ Protein G biosensor for rapid detection and quantification of numerous types of mammalian immunoglobulin (IgG), an antibody molecule, from solution. Because it runs on the company's label-free Octet instrumentation platform, the new biosensor enables such measurements with unprecedented speed, ease of use and cost-efficiency.

3 Sep 2010

Cardiogenesis Corporation releases comment on STAR-heart study

Cardiogenesis Corporation, released comments today regarding the STAR-heart study.The STAR-heart study, which was presented at the European Society of Cardiology 2010 Congress in August 2010, reported that the intracoronary injection of autologous stem cells derived from bone marrow is associated with improved hemodynamics and long term survival in the treatment of chronic heart failure.

3 Sep 2010

American Cancer Society attacks electronic cigarettes while number of users increase

The American Cancer Society continues to attack electronic cigarettes and falsely label them as dangerous and ineffective, while the number of people using the products is increasing by 20,000 to 30,000 a week. Despite the ACS's claims, e cigarette reviews by consumers are still flooding in all over the Internet that smokers who are switching to e cigarettes and e liquid are breathing, tasting, and sleeping better than they ever did while smoking traditional cigarettes.

3 Sep 2010

Data from ESC confirms reduction in adverse events with CYPHER Stent

Additional Analysis of 18 Month Data of the SORT OUT III Trial Provides Detail on Safety and Efficacy Outcomes in Patients With Diabetes, Acute Coronary Syndrome, or Treatment of Multiple Lesions

3 Sep 2010

Accentus Medical signs licence agreement for Agluna anti-infective technology with Zimmer

Accentus Medical, a leading UK medical technology company that supplies advanced coatings and surface treatments to the medical device industry, announced today that it has signed a Licence and Services Agreement with Zimmer Holdings, Inc., a global market leader in musculoskeletal care. This agreement will enable the use of Accentus Medical's Agluna® anti-infective technology on a potentially broad range of Zimmer products.

3 Sep 2010

Device / Technology News

Medtronic announces international launch of Resolute Integrity Stent System

DSM, PolyTherics enter agreement for HiPEG IFN alpha-2a product development

International Iberian Nanotechnology Laboratory orders for Vistec's EBPG5200 electron-beam lithography system

Ultrasound guidance helps radiologist to identify, treat self-embedding patients

Researchers decode words from brain signals in paralyzed people

Myconostica's MycAssay Aspergillus for serum granted CE marking

PennHIP radiographic method may hold potential to evaluate human susceptibility to hip dysplasia

Exmovere commences development of urban electric vehicle for active women

Study suggest PET/CT scanning may offer effective breast cancer detection, spread

MSKCC develops new prediction tool to calculate risk for DCIS recurrence after breast-conserving surgery

FDA approves IDE study to evaluate HeartWare Ventricular Assist System

Revolutions Medical signs Letter of Intent for manufacturing RevVac Safety Syringes

TNS therapy improves depression: Study

Virginia G. Piper Cancer Center at Scottsdale Healthcare offers free prostate cancer screenings

Transitions Optical launches 'Healthy Sight for Life: Focus on African-American Eyes' campaign

ForteBio launches Protein G biosensor for rapid detection of mammalian IgGs

Cardiogenesis Corporation releases comment on STAR-heart study

American Cancer Society attacks electronic cigarettes while number of users increase

Data from ESC confirms reduction in adverse events with CYPHER Stent

Accentus Medical signs licence agreement for Agluna anti-infective technology with Zimmer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News